Clinical Trial

Fatigue in MS: From Invisible to Measurable

Study acronym: FIMS
Completed
View on ClinicalTrials.gov →
Summary
Fatigue is one of the most common and burdensome symptoms of MS, but its precise cause remains unknown, and an effective treatment is lacking. Previous research has shown that the progression of MS is associated with a higher presence of a specific type of T-cell, the cytotoxic CD4+ T-cells, which play a role in the immune system. The aim of this study is to investigate whether these cells can also be linked to fatigue in people with MS.
Protocol Amendment History 2 changes
critical Trial completed 2026-04-21
notable Enrollment reduced: 40 -> 34 participants 2026-04-21
Trial Details
NCT Number NCT07182903
Lead Sponsor University Medical Center Groningen
Collaborators: UHasselt
Conditions Multiple Sclerosis
Enrollment 34 participants
Start Date 2025-10-27
Primary Completion 2026-04-02 (estimated)
Study Completion 2026-04-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-20